CHGCF
Price:
$55.41
Market Cap:
$13.55T
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; osteoporosis, including Actemra, Edirol, and Bonviva; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neurosci...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-08-03
Stock Exchange
OTC
Ticker
CHGCF
According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.07T. This represents a change of 16.97% compared to the average of 11.17T of the last 4 quarters.
The mean historical Enterprise Value of Chugai Pharmaceutical Co., Ltd. over the last ten years is 5.50T. The current 13.07T Enterprise Value has changed 23.64% with respect to the historical average. Over the past ten years (40 quarters), CHGCF's Enterprise Value was at its highest in in the June 2025 quarter at 11.90T. The Enterprise Value was at its lowest in in the December 2016 quarter at 1.74T.
Average
5.50T
Median
5.33T
Minimum
1.74T
Maximum
10.99T
Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 73.49%
Maximum Annual Enterprise Value = 10.99T
Minimum Annual Increase = -33.40%
Minimum Annual Enterprise Value = 1.74T
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 10.99T | 31.70% |
| 2023 | 8.34T | 56.49% |
| 2022 | 5.33T | -9.47% |
| 2021 | 5.89T | -33.40% |
| 2020 | 8.84T | 66.02% |
| 2019 | 5.33T | 59.20% |
| 2018 | 3.35T | 10.97% |
| 2017 | 3.01T | 73.49% |
| 2016 | 1.74T | -21.48% |
| 2015 | 2.21T | 47.37% |
The current Enterprise Value of Chugai Pharmaceutical Co., Ltd. (CHGCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.22T
5-year avg
7.88T
10-year avg
5.50T
Chugai Pharmaceutical Co., Ltd.’s Enterprise Value is greater than GSK plc (88.04B), greater than Daiichi Sankyo Company, Limited (6.02T), greater than Daiichi Sankyo Company, Limited (6.02T), greater than Siemens Healthineers AG (61.30B), greater than Merck KGaA (60.92B), greater than Merck KGaA (60.92B), greater than Sartorius AG (21.41B), greater than CSL Limited (69.64B), greater than HOYA Corporation (7.64T), greater than Ipsen S.A. (9.70B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 88.04B | $98.09B | |
| 6.02T | $42.52B | |
| 6.02T | $42.11B | |
| 61.30B | $55.30B | |
| 60.92B | $59.36B | |
| 60.92B | $60.45B | |
| 21.41B | $87.76B | |
| 69.64B | $58.95B | |
| 7.64T | $52.42B | |
| 9.70B | $46.43B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Chugai Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCF)?
What is the 3-year average Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCF)?
What is the 5-year average Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCF)?
How does the current Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCF) compare to its historical average?